AXCELIS ANNOUNCES MULTIPLE PURION M SHIPMENTS INCLUDING FOLLOW-ON ORDERS AND THREE NEW CUSTOMER TOOL PLACEMENTS

Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) reported multiple shipments of Purion M™ medium current implanters, enhancing its presence in the semiconductor industry. These include follow-on orders and three new placements across the US, Europe, and Asia, shipped in Q2 2022. Executive VP Bill Bintz noted that the mature process technology market continues to be robust, indicating potential revenue growth from these new tool placements. This strategic move aims to expand the company's customer base and revenues in a vital segment of the industry.

Positive

• Multiple shipments of Purion M implanters enhance market presence.
• Three new customer placements across US, Europe, and Asia.
• Strengthening position in the growing mature process technology market.

Negative

• None.

News Market Reaction – ACLS

+1.42%

+1.42% Session move

In the trading session that priced this news, ACLS gained 1.42%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEVERLY, Mass., May 23, 2022 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today multiple shipments of Purion M™ medium current implanters to mature process technology device makers. The shipments include follow-on orders and three new customer tool placements in the US, Europe and Asia. The systems shipped in the second quarter of 2022.  

Executive Vice President of Product Development, Bill Bintz, commented, "We're very pleased to announce these new wins for the Purion M platform. The growing mature process technology market continues to be an area of strength for Axcelis, and targeted Purion products for this market will play a key role in increasing our customer base and revenues in this segment. Our Purion M ion implanters are designed to address the diverse requirements of our customers offering unparalleled flexibility to meet today's evolving implant requirements."

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-multiple-purion-m-shipments-including-follow-on-orders-and-three-new-customer-tool-placements-301552412.html

SOURCE Axcelis Technologies, Inc.

FAQ

What recent shipments did Axcelis Technologies announce?

Axcelis announced multiple shipments of Purion M™ medium current implanters, including follow-on orders and three new customer tool placements.

When were the systems shipped by Axcelis Technologies?

The systems were shipped in the second quarter of 2022.

How is Axcelis Technologies performing in the semiconductor industry?

Axcelis is experiencing growth in the mature process technology market, which is a key area for expanding its customer base and revenues.

What is the significance of the Purion M platform for Axcelis?

The Purion M platform is aimed at meeting diverse customer requirements and is integral to increasing the company's revenues in the semiconductor sector.